Literature DB >> 56893

Alpha-fetoprotein.

H L Lau, S E Linkins.   

Abstract

Despite all the information about AFP presented, a great deal still needs to be discovered especially in pregnancy. Geographical and racial differences remain to be elucidated. Similarly, differences in obstetric population in Helsinki and Baltimore, for example, are only now being studied. Sex differences may exist; Lardinois and associates195 cited a higher level of AFP in male than female fetuses. The important questions that need to be answered are whether AFP assays can help improve the other half of prenatal care- that directed to the fetus- and whether the AFP model can help enhance our understanding of the similarities and differences of fetal and cancer cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56893     DOI: 10.1016/0002-9378(76)90184-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  Plasma protein binding of drugs in pregnancy and in neonates.

Authors:  L J Notarianni
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

2.  A comparison between the composition of maternal peripheral plasma and plasma collected from the retroplacental compartment at caesarean section. A study on protein and steroid hormones and binding proteins.

Authors:  M Norman; C G Eriksson; P Eneroth
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  [Alpha-fetoprotein (AFP) in amniotic fluid].

Authors:  G Pescia; A C Gaide; H Bossart
Journal:  Soz Praventivmed       Date:  1981-09

4.  Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.

Authors:  T Brenner; Y Beyth; O Abramsky
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.